After decades of little innovation in treatments for type 1 diabetes, the FDA is on track to approve Zynquista, the first oral antidiabetic drug in the US for adults with type 1 diabetes, by March 2019.
Current type 1 diabetes medications
At present, those with type 1 diabetes, also known as juvenile or insulin-dependent diabetes, use injectable or inhaled insulins to survive. Sometimes, they also use Symlin, an injectable non-insulin drug that makes patients feel full at meals, slows the rate at which food moves from the stomach into the small intestine, and stops the release of glucagon, a hormone that tells the liver to release sugar into the bloodstream. See More